Subscribe To
Vaccine stocks rising on booster news
Pfizer Inc (NYSE:PFE) and partner BioNTech SE (NASDAQ:BNTX) filed an application with the U.S. Food and Drug Administration this morning to approve em...
March 16, 2022, 11:00 am
Here's why moderna shares are rising
Moderna Inc (NASDAQ: MRNA) shares are trading higher by 7.0% at $158.42. The company announced today it has reached an agreement with Japan to supply ...
March 16, 2022, 10:55 am
Pfizer, biontech seek fda nod for 4th covid shot in older adults
Pfizer (PFE) and BioNTech (BNTX) believe that for individuals to be adequately protected, additional booster...
March 16, 2022, 9:47 am
Moderna says japanese government has ordered additional 70 million doses of its covid booster vaccine
Moderna Inc. MRNA, -1.30% said Wednesday the Japanese government has ordered an additional 70 million doses of its COVID-19 ...
March 16, 2022, 8:12 am
Pfizer reportedly will seek fda approval for a second vaccine booster for people 65 and older
Pfizer CEO Albert Bourla previously said that a fourth coronavirus vaccine is "necessary" to protect against COVID-19....
March 15, 2022, 1:28 pm
Pfizer reportedly set to request authorization for second covid booster shot for seniors
Pfizer-BioNTech will soon request FDA emergency authorization for a second Covid booster shot for peopl...
March 15, 2022, 1:15 pm
General electric (ge) arm clinches vsds contract from safran
General Electric's (GE) business unit secures a contract from Safran Aero boosters to provide electrica...
March 15, 2022, 12:03 pm
Moderna and biontech stocks rally on booster chatter and a china covid surge
Shares of Covid-19 vaccine makers jump on news of climbing Covid-19 cases in China and growing talk of a fourth ...
March 14, 2022, 12:23 pm
Pfizer ceo: the emergence of a new covid-19 variant is 'a likely scenario'
Pfizer CEO Albert Bourla spoke with Yahoo Finance's Julie Hyman at South by Southwest about the coronavirus pandemic, vaccine fatigue, ...
March 14, 2022, 11:32 am
Pfizer ceo says a fourth booster shot is 'necessary' to protect against covid-19
"It is necessary, a fourth booster right now," Albert Bourla said on CBS's "Face the Nation."...
March 13, 2022, 4:13 pm
Moderna (mrna) starts omicron-specific bivalent booster study
Moderna (MRNA) administers the first dose in the phase II study of its Omicron-specific bivalent booster...
March 11, 2022, 3:48 pm
Moderna begins phase 2 trial for bivalent covid-19 booster for 'fall booster season'
Shares of Moderna Inc. MRNA, +10.22% were down 1.9% in premarket trading on Thursday after the company said it began dosing patients in a Phase 2 clin...
March 10, 2022, 9:10 am
Pfizer ceo on booster development, ukraine refugee vaccinations
Pfizer Chairman and CEO Albert Bourla discusses his new book "Moonshot," progress on developing a fourth Covid-19 ...
March 8, 2022, 1:38 pm
Moderna ‘firmly' thinks another covid-19 booster will be necessary this fall
Moderna MRNA, +13.83% CEO Stéphane Bancel predicts that the next phase of the pandemic is here, and what we'll need going forward is a ...
February 24, 2022, 3:08 pm
Moderna ‘firmly' thinks another covid-19 booster will be necessary this fall
Moderna MRNA, +13.83% CEO Stéphane Bancel predicts that the next phase of the pandemic is here, and what we'll need going forward is a ...
February 24, 2022, 3:08 pm
Moderna ‘firmly' thinks another covid-19 booster will be necessary this fall
Moderna MRNA, +13.83% CEO Stéphane Bancel predicts that the next phase of the pandemic is here, and what we'll need going forward is a ...
February 24, 2022, 3:08 pm
Moderna bucks market slump as it ups forecast for covid-19 jab revenues
Moderna Inc bucked the slump in global markets after the vaccine maker last night upped its forecast for sales of its Covid jab. The US pharma now exp...
February 24, 2022, 9:39 am
Moderna bucks market slump as it ups forecast for covid-19 jab revenues
Moderna Inc bucked the slump in global markets after the vaccine maker last night upped its forecast for sales of its Covid jab. The US pharma now exp...
February 24, 2022, 9:39 am
Moderna bucks market slump as it ups forecast for covid-19 jab revenues
Moderna Inc bucked the slump in global markets after the vaccine maker last night upped its forecast for sales of its Covid jab. The US pharma now exp...
February 24, 2022, 9:39 am
Glaxosmithkline and sanofi plan to submit data from covid-19 booster and phase iii trials for approval
GlaxoSmithKline PLC (LSE:GSK) and Sanofi SA said they plan to submit data from their booster and Phase ...
February 23, 2022, 6:19 am